Impact of an enhanced anti-infection prophylaxis strategy for pancreatoduodenectomy: a single centre analysis

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
pancrea_thmbnl
Detail Image
pancrea_mbl
Book Detail
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

Enhanced anti-infective prophylaxis (EAP) has been found to significantly reduce surgical site infections (SSI) following pancreatoduodenectomy (PD), according to a recent study. The research aimed to evaluate the impact of EAP on both superficial and intraabdominal SSIs, particularly in patients who had undergone preoperative bile duct stenting—a group prone to antibiotic-resistant infections. Results suggest that implementing targeted, enhanced antibiotic prophylaxis can effectively lower infection rates and improve postoperative outcomes after PD.

Published Date